enGene Holdings Inc. Balance Sheet
ENGN / Health Care|4 years of annual SEC 10-K data (FY2022-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
enGene Holdings Inc. had $221M in total assets and $168M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash & Equivalents | $50.2M | $173.0M | $81.5M | $20.4M |
| Current Assets | $201.4M | $247.4M | $85.4M | $22.6M |
| PP&E (Net) | $2.5M | $1.2M | $589.0K | $387.0K |
| Total Assets | $221.5M | $311.2M | $87.0M | $23.9M |
| Current Liabilities | $32.0M | $14.7M | $5.3M | $5.1M |
| Shareholders' Equity | $167.7M | $272.6M | $72.5M | -$76.6M |